Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Foundation for Liver and Gut Studies (FLAGS) is a Hong Kong-based non-profit research organization dedicated to advancing the prevention, diagnosis, and treatment of liver and gastrointestinal diseases. Established by prominent hepatologists from the Chinese University of Hong Kong, the foundation serves as a critical hub for high-impact clinical research and investigator-initiated trials in the Asia-Pacific region. Its primary research focus includes chronic hepatitis B, metabolic dysfunction-associated steatotic liver disease (MASLD), and the development of non-invasive diagnostic tools for liver fibrosis. FLAGS collaborates extensively with global pharmaceutical companies and academic institutions to evaluate novel therapeutic agents and diagnostic biomarkers. The organization also plays a significant role in public health by conducting large-scale screening programs and providing medical education to healthcare professionals. Through its integration with clinical practice at the Prince of Wales Hospital, FLAGS translates scientific discoveries into improved patient care for liver disease.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Foundation for Liver and Gut Studies.